PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. ldu3@gsu.edu.\', \'Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, USA.\', \'Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, USA.\', \'Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USA.\', \'Center for Coronavirus Research, University of Minnesota, Saint Paul, Minnesota, USA. lifang@umn.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1039/d1nr03831a
?:hasPublicationType
?:journal
  • Nanoscale
is ?:pmid of
?:pmid
?:pmid
  • 35018939
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.934
?:rankingScore_hIndex
  • 152
is ?:relation_isRelatedTo_publication of
?:title
  • Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35018939>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35018939>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all